Real-world patient characteristics, treatment patterns and costs in relapsing multiple sclerosis patients treated with glatiramer acetate, dimethyl fumarate or teriflunomide in Germany

MS Treatments

Jahr

Publikationsjahr
2022

Autoren

Autorenliste der Publikation
Ziemssen T, Kurzeja A, Muresan B, Haas JS, Alexander J, Driessen MT.

Verlag

Publisher-Information
Neurodegenerative Dis Manage 2022;12(2):93-107.

Link

Zur Publikation (externer Server)
https://doi.org/10.2217/nmt-2021-0031

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2022